FDA-approved dimethyl fumarate targets thioredoxin reductase to induce apoptosis in triple-negative breast cancer.
- DOI
- 10.1016/j.freeradbiomed.2026.08.041
- Published
- 2026 Aug 20
- Container
- Free radical biology & medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.freeradbiomed.2026.08.041,
title = {FDA-approved dimethyl fumarate targets thioredoxin reductase to induce apoptosis in triple-negative breast cancer.},
author = {Duan D and Pu Y and Wang Y and Yang X and Li M and Jin X and Wang L and Xiao J and Wang X and Song P},
year = {2026},
journal = {Free radical biology \& medicine},
doi = {10.1016/j.freeradbiomed.2026.08.041},
url = {https://doi.org/10.1016/j.freeradbiomed.2026.08.041}
}RIS
TY - JOUR TI - FDA-approved dimethyl fumarate targets thioredoxin reductase to induce apoptosis in triple-negative breast cancer. AU - Duan D AU - Pu Y AU - Wang Y AU - Yang X AU - Li M AU - Jin X AU - Wang L AU - Xiao J AU - Wang X AU - Song P PY - 2026 JO - Free radical biology & medicine DO - 10.1016/j.freeradbiomed.2026.08.041 UR - https://doi.org/10.1016/j.freeradbiomed.2026.08.041 ER -
APA
D, D., Y, P., Y, W., X, Y., M, L., X, J., L, W., J, X., X, W., & P, S. (2026). FDA-approved dimethyl fumarate targets thioredoxin reductase to induce apoptosis in triple-negative breast cancer.. Free radical biology & medicine. https://doi.org/10.1016/j.freeradbiomed.2026.08.041
Source records
- pubmed · retrieved 2026-09-26T17:21:35.968Z